{"title":"Longitudinal Retinal and Choroidal Vascular Changes After Epiretinal Membrane Surgery: A 9-Month Swept-Source OCT Angiography Study.","authors":"Melike Balikoglu-Yilmaz, Sule Barman Kakil, Gulsum Yildirim Unal","doi":"10.1080/08820538.2026.2762143","DOIUrl":"https://doi.org/10.1080/08820538.2026.2762143","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate longitudinal retinal and choroidal vascular changes after epiretinal membrane (ERM) surgery using SS-OCTA and to compare postoperative trajectories between idiopathic and secondary ERM.</p><p><strong>Methods: </strong>In this prospective longitudinal study, eyes with idiopathic and secondary ERM undergoing surgery were evaluated at baseline and at postoperative months 1, 3, 6, and 9. Assessments included best-corrected visual acuity (BCVA), central macular thickness (CMT), foveal avascular zone (FAZ) area, superficial and deep capillary plexus vessel density (SCP and DCP VD), subfoveal choroidal thickness (SfCT), choroidal vascularity index (CVI), and choriocapillaris flow metrics. Fellow eyes without ERM or other macular pathology served as patient-matched internal controls.</p><p><strong>Results: </strong>In the overall ERM cohort, BCVA improved from 1.00 ± 0.40 logMAR at baseline to 0.64 ± 0.31 logMAR at month 9, while CMT decreased from 402.06 ± 82.79 to 300.68 ± 53.61 µm (both <i>p</i> < .001). FAZ area progressively increased from 129.73 ± 36.85 to 213.06 ± 36.89 × 10<sup>-3</sup> mm<sup>2</sup> (<i>p</i> < .001), although it remained smaller than in fellow eyes. At month 9, FAZ area was larger in the idiopathic than in the secondary ERM group (227.82 vs 200.07 × 10<sup>-3</sup> mm<sup>2</sup>; <i>p</i> = .007). In both idiopathic and secondary ERM groups, SCP and choriocapillaris parameters remained largely stable, whereas the DCP showed limited sectoral recovery. SfCT decreased over time, while CVI showed no significant longitudinal change.</p><p><strong>Conclusion: </strong>ERM surgery resulted in significant improvement in BCVA and reduction in CMT over 9 months, although both remained different from fellow eyes. FAZ area progressively enlarged after surgery but remained smaller than in fellow eyes, with greater late enlargement in idiopathic ERM. Retinal vessel density changes were limited and sector-specific, while choroidal parameters remained largely stable.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-10"},"PeriodicalIF":3.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"120° Widefield SS-OCTA Assessment of Retinal and Choroidal Vascular Changes After Panretinal Photocoagulation in Severe NPDR.","authors":"Jiyuan Zhong, Chong Tang, Ke Hu, Rong Hu","doi":"10.1080/08820538.2026.2761423","DOIUrl":"https://doi.org/10.1080/08820538.2026.2761423","url":null,"abstract":"<p><strong>Objective: </strong>To investigate retinal and choroidal blood vascular changes before and after panretinal photocoagulation (PRP) in severe non-proliferative diabetic retinopathy (NPDR) patients using widefield swept-source optical coherence tomography angiography (SS-OCTA) covering 120° fundus.</p><p><strong>Methods: </strong>A prospective longitudinal study enrolled 55 patients with type 2 diabetes mellitus and severe non-proliferative diabetic retinopathy (NPDR), contributing 95 eyes scheduled for PRP, which was administered in four weekly sessions. SS-OCTA scanning (6 mm × 6 mm and 24 mm × 20 mm mode) was performed pre- and 3 months post-PRP. Quantitative parameters included foveal avascular zone (FAZ) size and vessel density (VD) of superficial retinal vessels (SRV), deep retinal vessels (DRV), choriocapillaris (CC), and large and medium choroidal vessels (LMVC).</p><p><strong>Results: </strong>Compared to pre-PRP values, significant reductions in VD were observed in the DRV (<i>p</i> < .0001) and CC layers (<i>p</i> < .0001) at 3 months after PRP. Reductions in VD were also observed in the SRV and LMVC layers (<i>p</i> = .02, <i>p</i> = .0118, respectively) before and 3 months after PRP. FAZ size and logarithm of the minimum angle of resolution best-corrected visual acuity (BCVA) remained unchanged before and 3 months after PRP. FAZ size was positively correlated with BCVA at both pre-PRP and 3-month post-PRP assessments.</p><p><strong>Conclusion: </strong>Widefield SS-OCTA demonstrates that PRP in severe NPDR induces layer-specific microvascular reductions, most pronounced in the deep retina and CC, concurrent with reduced VD of LMVC layer, while preserving central macular structure and function at 3 months after PRP.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-7"},"PeriodicalIF":3.1,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149395267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Omar Ashraf Ibrahim, Basma Kamel, Alaa H Ewida, Noha Abd El-Moez, Reham Sayed Ramadan Mostafa, Ahmed Medhat, Hend Khalifa, Moaz Yasser Darwish, Mostafa M Diab
{"title":"Botulinum Toxin Injection Versus Conjunctivodacryocystorhinostomy for Epiphora Secondary to Proximal Lacrimal Obstruction: A Systematic Review and Meta-Analysis.","authors":"Omar Ashraf Ibrahim, Basma Kamel, Alaa H Ewida, Noha Abd El-Moez, Reham Sayed Ramadan Mostafa, Ahmed Medhat, Hend Khalifa, Moaz Yasser Darwish, Mostafa M Diab","doi":"10.1080/08820538.2026.2762504","DOIUrl":"https://doi.org/10.1080/08820538.2026.2762504","url":null,"abstract":"<p><strong>Purpose: </strong>To systematically evaluate the efficacy and safety of lacrimal gland botulinum toxin (BTX) injection and conjunctivodacryocystorhinostomy (CDCR) in proximal lacrimal system obstruction.</p><p><strong>Methods: </strong>PubMed, Web of Science, Scopus, and Cochrane CENTRAL were systematically searched through December 2025 for studies evaluating BTX injection or CDCR. Data on study characteristics, patient demographics, follow-up, efficacy outcomes including Munk score and Schirmer test, and adverse events were extracted. Pooled outcomes were estimated using random-effects models, with subgroup analyses and meta-regression performed to explore between-study heterogeneity.</p><p><strong>Results: </strong>Twenty-one studies were included. These included four studies addressing BTX, sixteen addressing CDCR, and one study comparing between both BTX and CDCR. BTX was associated with significant improvement in epiphora symptoms (Munk score standardized mean difference [SMD], 1.64; 95% confidence interval [CI], 1.19-2.10) and reduced tear production (Schirmer test SMD: 0.74; 95% CI: 0.34-1.15), with no detected heterogeneity for either outcome (I<sup>2</sup> = 0%). The pooled BTX success rate was 84% (95% CI: 76%-90%; I<sup>2</sup> = 14.6%). Primary CDCR had a pooled success rate of 79% (95% CI: 62%-92%; I<sup>2</sup> = 92.6%); whereas revision CDCR has a pooled success of 56%. Exploratory indirect subgroup comparison showed no statistically significant difference between BTX and primary CDCR estimates (<i>p</i> = .483). BTX-related adverse events were generally transient, whereas CDCR complications were mainly mechanical and device-related.</p><p><strong>Conclusion: </strong>Lacrimal gland BTX injection was associated with substantial symptomatic improvement, reduced tear production, and relatively consistent outcomes across studies. Primary CDCR also demonstrated favorable success rates but with considerable between study-heterogeneity and device-related morbidity. Current evidence does not establish equivalence or superiority between the two approaches. Modern retentive tubes may reduce malposition risk compared with classic designs.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-13"},"PeriodicalIF":3.1,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149387720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cellphone-Associated Ocular Injuries Presenting to U.S. Emergency Departments.","authors":"Nicholas Whitcomb, Grayson W Armstrong","doi":"10.1080/08820538.2026.2757125","DOIUrl":"https://doi.org/10.1080/08820538.2026.2757125","url":null,"abstract":"<p><strong>Purpose: </strong>To characterize national trends, mechanisms, and demographic patterns of cellphone-associated ocular injuries over 20 years using a nationally representative database.</p><p><strong>Methods: </strong>Retrospective cross-sectional study using the National Electronic Injury Surveillance System (NEISS) database, encompassing emergency department (ED) visits from approximately 100 nationally representative U.S. hospitals. Cellphone-associated eye injuries, which encompass cases of globe injury where cellphones or their accessories were involved, were identified and analyzed for patient demographics, clinical information, context of injury, and weighted national estimates. Temporal trends in ED visit rates were analyzed using joinpoint regression, and annual percent changes (APCs) quantified changes in ED visit rates.</p><p><strong>Results: </strong>Between 2004 and 2023, an estimated 16,107 ED visits from cellphone-associated eye injuries (95% CI, 13,280-18,933) were recorded in NEISS. By joinpoint analysis, ED visit rates increased significantly from 2008-2015 (APC, 22.4%; 95% CI, 9.7%-36.5%), and no statistically significant trend was observed from 2004-2008 (APC, 1.0%; 95% CI,15.9%-21.2%) or from 2015-2023 (APC, -3.9%; 95% CI, 12.1%-5.1%). Open globe injuries occurred in seven reported cases, representing 252 weighted-estimated ED visits (95% CI, 33-471) or 1.6% of all estimated ED visits. Direct mechanical (DM) injuries accounted for 83.2% (weighted <i>n</i> = 13,401, 95% CI, 11,002-15,800) of ED visits, predominantly from the phone body (46.2%) and screen glass (32.6%). Use-associated (UA) injuries comprised 16.8% weighted (<i>n</i> = 2,705, 95% CI, 1,641-3,770), with distraction-mediated activities (62.7%) being most common.</p><p><strong>Conclusions: </strong>Cellphone-associated ocular ED visits increased substantially from 2008 to 2015, while no statistically significant change was detected between 2015 and 2023. Direct mechanical trauma, broken screen glass, and distraction represent commonly identified mechanisms. Eye care professionals should counsel patients on responsible handling of phones and accessories, limiting phone use while walking or driving, replacement of broken screens, and the importance of prompt assessment after penetrating or significant ocular trauma.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-8"},"PeriodicalIF":3.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jai Paris, Carmelo Macri, Fady K Sammouh, Walid Dandan, Paul Badenoch, Weng Onn Chan, Mark Chehade
{"title":"Intrastromal Antibiotic Therapy for Recalcitrant Bacterial Keratitis.","authors":"Jai Paris, Carmelo Macri, Fady K Sammouh, Walid Dandan, Paul Badenoch, Weng Onn Chan, Mark Chehade","doi":"10.1080/08820538.2026.2756326","DOIUrl":"https://doi.org/10.1080/08820538.2026.2756326","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and efficacy of adjunctive intrastromal vancomycin and meropenem for the treatment of recalcitrant bacterial keratitis.</p><p><strong>Methods: </strong>We conducted a single-center, retrospective, non-comparative cohort study of consecutive patients with recalcitrant bacterial keratitis treated at a major tertiary center between January 2022 and April 2026. We included adults with suspected or culture‑proven bacterial keratitis failing topical therapy and meeting inclusion criteria. All underwent corneal scraping and adjunctive intrastromal vancomycin (5 mg/mL) and meropenem (20 mg/mL) using a circumferential barrage technique. Repeat injection at 48 hours was determined by a senior corneal specialist according to clinical response. The primary outcome was clinical resolution. Secondary outcomes included epithelial healing, reinjection, and complications.</p><p><strong>Results: </strong>Twenty eyes of 20 patients were included. At 28 days, 19/20 eyes (95%) achieved clinical resolution of stromal infiltrate and infection. Epithelial defects were present in 18/20 (90%) at baseline, with size reduction in 15/18 (75%) at early follow-up (median 2 days). Median time to complete epithelial healing was 12 weeks (range 10-16 weeks). Six eyes (30%) required reinjection. One eye progressed to perforation requiring penetrating keratoplasty. No direct injection-related adverse events were observed. Gram-positive organisms predominated (13/20, 65%), with polymicrobial infection in 3/20 (15%) and no growth in 3/20 (15%) cases.</p><p><strong>Conclusions: </strong>Adjunctive intrastromal antibiotic therapy achieved a high rate of infection resolution in this cohort of recalcitrant bacterial keratitis, with a low complication rate. This approach may be considered in refractory cases or when unable to utilize conventional topical therapy. However, further evaluation of its role is needed in larger comparative studies.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-7"},"PeriodicalIF":3.1,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dmitrii S Maltsev, Alexey N Kulikov, Yana A Kalinicheva, Jay Chhablani
{"title":"Effects of Topical Fluorometholone in Chronic Central Serous Chorioretinopathy: A Proof-Of-Concept Study.","authors":"Dmitrii S Maltsev, Alexey N Kulikov, Yana A Kalinicheva, Jay Chhablani","doi":"10.1080/08820538.2026.2758869","DOIUrl":"https://doi.org/10.1080/08820538.2026.2758869","url":null,"abstract":"<p><strong>Purpose: </strong>To study the effects of topical fluorometholone on the activity of chronic central serous chorioretinopathy (CSCR) and the associated structural changes of the sclera.</p><p><strong>Methods: </strong>Patients with chronic CSCR were included in this prospective, randomized, controlled study. All participants were randomly assigned to either observation or receiving topical fluorometholone 0.1% four times daily. Scleral thickness was measured using anterior segment optical coherence tomography. Changes in central retinal thickness (CRT), subfoveal choroidal thickness (SCT), and scleral thickness were evaluated. Correlation of fluorometholone effects with baseline characteristics was assessed.</p><p><strong>Results: </strong>Forty-five eyes of 45 patients (34 males [75.5%], mean age 50.5 ± 10.9 years) were included in the treatment group, and 30 eyes of 30 patients (24 males [80.0%], mean age 52.1 ± 12.0 years) were included in the control group. After 4.7 ± 2.6 weeks of topical treatment, mean changes of CRT, SCT, and scleral thickness were -50.3 ± 136.5, -28.6 ± 40.3, and -26.9 ± 37.3 µm (<i>p</i> < .05). Fourteen (31.1%) eyes had complete resolution of exudation in the treatment group. No cases of complete resolution of exudation were observed in the control group (<i>p</i> < .001) after 3 months of follow-up. Effects of topical fluorometholone were associated with male gender, absence of choroidal neovascularization, shorter axial length, peripapillary leakage, ciliochoroidal detachment, intraretinal fluid, thicker sclera at baseline, and reduction of scleral thickness during treatment (for all, <i>p</i> < .05). Recurrence of activity after discontinuation of topical fluorometholone was observed in all 14 eyes with initial resolution of exudation. The median time to recurrence was 2.0 months (95% CI 2.0 to 3.5).</p><p><strong>Conclusions: </strong>Topical fluorometholone may temporarily reduce exudation in chronic CSCR without choroidal neovascularization in eyes with thick sclera, short axial length, peripapillary leakage, and intraretinal fluid. Remodeling of the scleral anatomy may be responsible for the effects of topical steroids in chronic CSCR. However, the fully reversible nature of these effects does not currently allow topical steroids to be considered a long-term strategy.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-9"},"PeriodicalIF":3.1,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in OphthalmologyPub Date : 2026-11-01Epub Date: 2025-11-06DOI: 10.1080/08820538.2025.2585700
Mohammad Javed Ali
{"title":"Lacrimal History - Part 75: Doyens of Dacryology Series - Fano Salvador (1824-1895) and His Lacrimal Pump Device, Concepts of Lacrimal Sac Catarrh and Its Histology.","authors":"Mohammad Javed Ali","doi":"10.1080/08820538.2025.2585700","DOIUrl":"10.1080/08820538.2025.2585700","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"864-871"},"PeriodicalIF":3.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in OphthalmologyPub Date : 2026-11-01Epub Date: 2025-11-06DOI: 10.1080/08820538.2025.2585715
Mohammad Javed Ali
{"title":"Lacrimal History - Part 78: Doyens of Dacryology Series - Ferdinand Leopold Kersten (1804-1853) and His 1828 Doctoral Thesis on Dacryoliths.","authors":"Mohammad Javed Ali","doi":"10.1080/08820538.2025.2585715","DOIUrl":"10.1080/08820538.2025.2585715","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"872-875"},"PeriodicalIF":3.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145459366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in OphthalmologyPub Date : 2026-11-01Epub Date: 2025-11-18DOI: 10.1080/08820538.2025.2589607
Mohammad Javed Ali
{"title":"Lacrimal History - Part 77: Doyens of Dacryology Series - Jakob Stilling (1842-1915) and Charles Hermon Thomas and the Early Concepts of Lacrimal Stricturoplasty Using Stricturotomoes.","authors":"Mohammad Javed Ali","doi":"10.1080/08820538.2025.2589607","DOIUrl":"10.1080/08820538.2025.2589607","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"880-885"},"PeriodicalIF":3.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145550093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in OphthalmologyPub Date : 2026-11-01Epub Date: 2026-02-18DOI: 10.1080/08820538.2026.2629879
Niloufar Bineshfar, Leo Meller, Andrew J Rong, Thomas E Johnson, Wendy W Lee
{"title":"Immune Checkpoint Inhibitors for the Treatment of Periorbital Non-Melanoma Skin Cancers.","authors":"Niloufar Bineshfar, Leo Meller, Andrew J Rong, Thomas E Johnson, Wendy W Lee","doi":"10.1080/08820538.2026.2629879","DOIUrl":"10.1080/08820538.2026.2629879","url":null,"abstract":"<p><strong>Purpose: </strong>Non-melanoma skin cancers (NMSCs) of the periocular region present significant clinical challenges, with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) being the most prevalent. The purpose of this study is to report on the outcomes of anti-programmed death (PD-1)/PD-L1 immunotherapy in patients with locally advanced periorbital NMSCs.</p><p><strong>Methods: </strong>We conducted a retrospective study of the patients treated for locally advanced periocular BCC and cutaneous SCC using anti-PD-1/PD-L1 immunotherapy from January 2016 to January 2023. Patient records were reviewed for clinical and histological data, and all were evaluated for the effectiveness of the therapy.</p><p><strong>Results: </strong>The study included nine patients with a mean age of 68.2 years. Four patients had periocular BCC, and five had cutaneous SCC. Most patients had received prior treatments, including surgical resection, radiation, and systemic chemotherapy. Six patients were treated with cemiplimab, one with nivolumab, one with pembrolizumab, and one underwent trials of all three medications. Anti-PD-1/PD-L1 therapy proved effective in two patients with BCC and two with SCC. All responsive cases were treated with cemiplimab.</p><p><strong>Conclusion: </strong>Anti-PD-1/PD-L1 immunotherapy appears to be a promising option for treating locally advanced periocular BCC and cutaneous SCC, especially in cases where traditional treatments fail. Future research should involve nationwide databases or multi-institutional collaborations to validate the results and clarify the use of immune checkpoint inhibitors for periorbital NMSCs as adjuvant therapy.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"931-936"},"PeriodicalIF":3.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146214118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}